Skip to content

Author

R. Płoski

We have 3 of 48 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Plasma Lipidomic Phenotype Associated with Pathogenic LDLR Variants in Familial Hypercholesterolemia

Familial hypercholesterolemia (FH) is caused by an impaired ability to clear circulating low-density lipoprotein (LDL-C) particles due to a defective low-density lipoprotein receptor (LDLR). FH significantly increases cardiovascular risk (CVR). Although conventional lipid parameters are essential for diagnosing FH, the...

Joanna Waś, Aleksander Prejbisz, M. Niedolistek et al. · 0 citations
Open access Aug 2026

EP1137 - ECE_2413 - The importance of cell adhesion molecules CADM2/3 and miR-127 and miR432 for clinically non-functioning pituitary tumours

Novel genes and miRs are revealed in NF-PitNETs suggesting their potential regulatory role in cell adhesion, migration, and apoptosis therefore potentially contributing to their pathogenesis.

B. Rak-Makowska, S. Barry, M. Maksymowicz et al. · 0 citations
Open access Jul 2026

TANGO2-related metabolic encephalopathy–arrhythmia syndrome unmasked in 22q11.2 deletion syndrome: hemizygous pathogenic variant, complex phenotype modified by two genetic conditions, and implications for proactive crisis prevention: a case report

A case of a child with confirmed 22q11.2 deletion syndrome in whom a coexisting variant in the TANGO2 gene was diagnosed at the age of 5 after first metabolic crisis with rhabdomyolysis, demonstrating that exome sequencing should be pursued early when atypical features emerge in patients with established genetic diagno...

Ewa Grzywna-Rozenek, Ł. Sędek, M. Rydzanicz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.